Masashi Sawa
Anjo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 205 publications
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
Fatal differentiation syndrome-associated myocarditis caused by PML: RARα-positive neutrophils in acute promyelocytic leukemia.
Journal: Leukemia & lymphoma
Published: August 06, 2026
Clinical Relevance of Transplant Conditioning Intensity Score-Based Refinement of Conditioning Intensity in Cord Blood Transplantation for Myelodysplastic Syndrome.
Journal: Transplantation and cellular therapy
Published: June 27, 2026
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.
Journal: Transplantation and cellular therapy
Published: May 25, 2026
Comparison of post-transplant cyclophosphamide and low-dose anti-thymocyte globulin with dose-dependent effects in mismatched unrelated donor transplantation.
Journal: British journal of haematology
Published: May 14, 2026
Morphologic Leukemia-Free State after Venetoclax-Based Therapy in Acute Myeloid Leukemia is Associated with High Relapse Despite Preserved Short-Term Survival.
Journal: Mediterranean journal of hematology and infectious diseases
Published: April 22, 2026
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
Journal: Bone marrow transplantation
Published: March 18, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.
Journal: Scientific reports
Published: March 16, 2026
Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.
Journal: Cytotherapy
Published: March 09, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient age.
Journal: Transplantation and cellular therapy
Published: February 19, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 05, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.
Journal: International journal of hematology
Published: January 17, 2026
Last Updated: 09/26/2026